Global Oral Colchicine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Colchicine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral colchicine refers to the formulation of the medication colchicine that is intended for oral administration. Colchicine is a medication derived from the plant Colchicum autumnale, also known as the autumn crocus or meadow saffron. It has been used for centuries as a medicinal agent, particularly in the treatment of gout and other inflammatory conditions.
Oral colchicine is available in the form of tablets or capsules, and it is typically taken by mouth. The medication is rapidly absorbed in the gastrointestinal tract and enters the bloodstream to exert its effects. Colchicine works by inhibiting inflammation and reducing the buildup of uric acid crystals in the joints, which is the underlying cause of gout.
Oral Colchicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Colchicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Gout and Familial Mediterranean Fever (FMF) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Colchicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Oral Colchicine key manufacturers include Hikma Pharmaceuticals, Takeda Pharmaceuticals, Viatris, ROMEG Therapeutics, Major Pharmaceuticals, Zydus Pharmaceuticals, Par Pharmaceuticals and KPC Pharmaceuticals, etc. Hikma Pharmaceuticals, Takeda Pharmaceuticals, Viatris are top 3 players and held % sales share in total in 2022.
Oral Colchicine can be divided into Oral Tablet, Oral Capsule and Oral Solution,, etc. Oral Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Colchicine is widely used in various fields, such as Gout, Familial Mediterranean Fever (FMF), Pericarditis and Others, etc. Gout provides greatest supports to the Oral Colchicine industry development. In 2022, global % sales of Oral Colchicine went into Gout filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Colchicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hikma Pharmaceuticals
Takeda Pharmaceuticals
Viatris
ROMEG Therapeutics
Major Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceuticals
KPC Pharmaceuticals
Segment by Type
Oral Tablet
Oral Capsule
Oral Solution
Gout
Familial Mediterranean Fever (FMF)
Pericarditis
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Colchicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Colchicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Colchicine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Colchicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Colchicine introduction, etc. Oral Colchicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Colchicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Oral colchicine is available in the form of tablets or capsules, and it is typically taken by mouth. The medication is rapidly absorbed in the gastrointestinal tract and enters the bloodstream to exert its effects. Colchicine works by inhibiting inflammation and reducing the buildup of uric acid crystals in the joints, which is the underlying cause of gout.
Oral Colchicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Colchicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Gout and Familial Mediterranean Fever (FMF) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Colchicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Oral Colchicine key manufacturers include Hikma Pharmaceuticals, Takeda Pharmaceuticals, Viatris, ROMEG Therapeutics, Major Pharmaceuticals, Zydus Pharmaceuticals, Par Pharmaceuticals and KPC Pharmaceuticals, etc. Hikma Pharmaceuticals, Takeda Pharmaceuticals, Viatris are top 3 players and held % sales share in total in 2022.
Oral Colchicine can be divided into Oral Tablet, Oral Capsule and Oral Solution,, etc. Oral Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Colchicine is widely used in various fields, such as Gout, Familial Mediterranean Fever (FMF), Pericarditis and Others, etc. Gout provides greatest supports to the Oral Colchicine industry development. In 2022, global % sales of Oral Colchicine went into Gout filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Colchicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hikma Pharmaceuticals
Takeda Pharmaceuticals
Viatris
ROMEG Therapeutics
Major Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceuticals
KPC Pharmaceuticals
Segment by Type
Oral Tablet
Oral Capsule
Oral Solution
Segment by Application
Gout
Familial Mediterranean Fever (FMF)
Pericarditis
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Colchicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Colchicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Colchicine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Colchicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Colchicine introduction, etc. Oral Colchicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Colchicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices